Alle weiteren Präsentationen unter https://boerse-social.com/austrianworldwideroadshow
evotec - The R&D Autobahn to Cures (06.06.2021)
evotec - forward looking statement (06.06.2021)
evotec - Agenda (06.06.2021)
evotec - Unique business model (06.06.2021)
evotec - The innovation hub in R&D (06.06.2021)
evotec - Innovation hub that meets industry needs (06.06.2021)
evotec - Megatrends support vision of more precise and accessible drugs (06.06.2021)
evotec - Multi-modality increasingly opens new doors to cures (06.06.2021)
evotec - Leadership in efficiency, data, science, multimodality and access (06.06.2021)
evotec - Clearly defined work packages allow increased access (06.06.2021)
evotec - New technologies, more precision, higher speed and efficiency (06.06.2021)
evotec - "...just starting" to deliver significant growth and value potential (06.06.2021)
evotec - Offering resonates with partners (06.06.2021)
evotec - Data-driven precision platforms on all modalities (06.06.2021)
evotec - Early insight to disease relevance drives paradigm shift (06.06.2021)
evotec - Precision medicine is our focus (06.06.2021)
evotec - Molecular patient data bases are re-defining health and disease (06.06.2021)
evotec - Molecular patient databases generate significant value (06.06.2021)
evotec - Unparalleled IPSC platform delivers big portfolio of opportunities (06.06.2021)
evotec - >300 patient-derived validated IPSC lines (06.06.2021)
evotec - Systems approach creates continuous learning from data (06.06.2021)
evotec - The time is now for more access to biologics (06.06.2021)
evotec - Co-owned pipeline building (06.06.2021)
evotec - Building a massive co-owned clinical pipeline (06.06.2021)
evotec - "EVOroyalty" Fully invested pipeline gaining visibility (06.06.2021)
evotec - The iceberg of EVT innovate product opportunities (06.06.2021)
evotec - From BRIDGES to operational VC (06.06.2021)
evotec - Portfolio of co-owned opportunities with operational synergies (06.06.2021)
evotec - BRIDGEs to link academia with R&D Autobahn to Cures (06.06.2021)
evotec - Financials, Governance & Outlook (06.06.2021)
evotec - Action plans deliver significant value (06.06.2021)
evotec - Strong growth while investing into long-term massive upside (06.06.2021)
evotec - Our mid-term aspirations at a glance (06.06.2021)
evotec - >500 new "drivers" on the data-driven R&D Autobahn for Cures (06.06.2021)
evotec - ESG & Sustainability - Committed to take action (06.06.2021)
evotec - Strong team and shareholders supporting sustainable growth (06.06.2021)
evotec - Strong year ahead (06.06.2021)
evotec - Strong news flow and strategy update with action plan 2025 (06.06.2021)
evotec - Contact (06.06.2021)
Gabriele Basilico
Essick Peter
Federico Clavarino